Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023
Thu, October 12, 2023

Jonathan Block Downgraded (ARQT) to Hold and Decreased Target to $6 on, Oct 13th, 2023

Jonathan Block of Goldman Sachs, Downgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Hold and Decreased Target from $32 to $6 on, Oct 13th, 2023.

Jonathan has made no other calls on ARQT in the last 4 months.



There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Jonathan


  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $57 on, Monday, September 25th, 2023
  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Tuesday, August 22nd, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Thursday, August 10th, 2023
  • Ken Cacciatore of "TD Cowen" Maintained at Buy with Decreased Target to $50 on, Wednesday, August 9th, 2023